Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

INTRODUCTION: Diabetes mellitus affects 9% of the European population and accounts for 15% of healthcare expenditure, in particular, due to excess costs related to complications. Clinical trials aiming for earlier prevention of diabetic nephropathy by renin angiotensin system blocking treatment in n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Lindhardt, Morten, Persson, Frederik, Currie, Gemma, Pontillo, Claudia, Beige, Joachim, Delles, Christian, von der Leyen, Heiko, Mischak, Harald, Navis, Gerjan, Noutsou, Marina, Ortiz, Alberto, Ruggenenti, Piero Luigi, Rychlik, Ivan, Spasovski, Goce, Rossing, Peter
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Diabetes and Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785328/
https://ncbi.nlm.nih.gov/pubmed/26936907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-010310
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars